Medioni J et al. |
Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patients. |
2014 |
Clin. Cancer Res. |
pmid:25013124
|
González-Pardo V et al. |
Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent. |
2014 |
J. Steroid Biochem. Mol. Biol. |
pmid:24316429
|
Van Belle TL et al. |
1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients. |
2014 |
PLoS ONE |
pmid:25279717
|
Ferreira GB et al. |
A proteomic approach on the effects of TX527, a 1α,25-dihydroxyvitamin D3 analog, in human T lymphocytes. |
2014 |
J. Steroid Biochem. Mol. Biol. |
pmid:24176759
|
Verlinden L et al. |
The vitamin D analog TX527 ameliorates disease symptoms in a chemically induced model of inflammatory bowel disease. |
2013 |
J. Steroid Biochem. Mol. Biol. |
pmid:23000190
|
Ferreira GB et al. |
1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study. |
2013 |
J. Steroid Biochem. Mol. Biol. |
pmid:23098690
|
Ma Y et al. |
Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system. |
2013 |
Cell Cycle |
pmid:23388458
|
González-Pardo V et al. |
Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus. |
2013 |
Br. J. Pharmacol. |
pmid:23647513
|
Okamoto R et al. |
Inecalcitol, an analog of 1α,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells. |
2012 |
Int. J. Cancer |
pmid:21732345
|
Baeke F et al. |
Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes. |
2012 |
Diabetologia |
pmid:22752077
|